Experience on the long-term use of canakinumab in mevalonate kinase deficiency: A case series

Int J Rheum Dis. 2024 May;27(5):e15192. doi: 10.1111/1756-185X.15192.
No abstract available

Publication types

  • Case Reports
  • Lecture
  • Letter
  • Case Reports

MeSH terms

  • Adolescent
  • Adult
  • Antibodies, Monoclonal, Humanized* / therapeutic use
  • Child
  • Humans
  • Male
  • Mevalonate Kinase Deficiency* / drug therapy
  • Young Adult

Substances

  • canakinumab
  • Antibodies, Monoclonal, Humanized

Grants and funding